Literature DB >> 34725519

Super-resolution microscopy: a closer look at synaptic dysfunction in Alzheimer disease.

Pranesh Padmanabhan1, Andrew Kneynsberg2, Jürgen Götz3.   

Abstract

The synapse has emerged as a critical neuronal structure in the degenerative process of Alzheimer disease (AD), in which the pathogenic signals of two key players - amyloid-β (Aβ) and tau - converge, thereby causing synaptic dysfunction and cognitive deficits. The synapse presents a dynamic, confined microenvironment in which to explore how key molecules travel, localize, interact and assume different levels of organizational complexity, thereby affecting neuronal function. However, owing to their small size and the diffraction-limited resolution of conventional light microscopic approaches, investigating synaptic structure and dynamics has been challenging. Super-resolution microscopy (SRM) techniques have overcome the resolution barrier and are revolutionizing our quantitative understanding of biological systems in unprecedented spatio-temporal detail. Here we review critical new insights provided by SRM into the molecular architecture and dynamic organization of the synapse and, in particular, the interactions between Aβ and tau in this compartment. We further highlight how SRM can transform our understanding of the molecular pathological mechanisms that underlie AD. The application of SRM for understanding the roles of synapses in AD pathology will provide a stepping stone towards a broader understanding of dysfunction in other subcellular compartments and at cellular and circuit levels in this disease.
© 2021. Springer Nature Limited.

Entities:  

Mesh:

Year:  2021        PMID: 34725519     DOI: 10.1038/s41583-021-00531-y

Source DB:  PubMed          Journal:  Nat Rev Neurosci        ISSN: 1471-003X            Impact factor:   34.870


  217 in total

1.  Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment.

Authors:  C R Jack; R C Petersen; Y C Xu; P C O'Brien; G E Smith; R J Ivnik; B F Boeve; S C Waring; E G Tangalos; E Kokmen
Journal:  Neurology       Date:  1999-04-22       Impact factor: 9.910

2.  Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

Authors:  R Brookmeyer; S Gray; C Kawas
Journal:  Am J Public Health       Date:  1998-09       Impact factor: 9.308

Review 3.  Synaptic Impairment in Alzheimer's Disease: A Dysregulated Symphony.

Authors:  Stefania Forner; David Baglietto-Vargas; Alessandra C Martini; Laura Trujillo-Estrada; Frank M LaFerla
Journal:  Trends Neurosci       Date:  2017-05-08       Impact factor: 13.837

4.  Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models.

Authors:  Lars M Ittner; Yazi D Ke; Fabien Delerue; Mian Bi; Amadeus Gladbach; Janet van Eersel; Heidrun Wölfing; Billy C Chieng; MacDonald J Christie; Ian A Napier; Anne Eckert; Matthias Staufenbiel; Edna Hardeman; Jürgen Götz
Journal:  Cell       Date:  2010-07-22       Impact factor: 41.582

5.  Somatodendritic accumulation of Tau in Alzheimer's disease is promoted by Fyn-mediated local protein translation.

Authors:  Chuanzhou Li; Jürgen Götz
Journal:  EMBO J       Date:  2017-09-01       Impact factor: 11.598

6.  Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model.

Authors:  Erik D Roberson; Kimberly Scearce-Levie; Jorge J Palop; Fengrong Yan; Irene H Cheng; Tiffany Wu; Hilary Gerstein; Gui-Qiu Yu; Lennart Mucke
Journal:  Science       Date:  2007-05-04       Impact factor: 47.728

Review 7.  Granulovacuolar degeneration: a neurodegenerative change that accompanies tau pathology.

Authors:  Christoph Köhler
Journal:  Acta Neuropathol       Date:  2016-04-09       Impact factor: 17.088

Review 8.  Amyloid-β and tau complexity - towards improved biomarkers and targeted therapies.

Authors:  Juan Carlos Polanco; Chuanzhou Li; Liviu-Gabriel Bodea; Ramon Martinez-Marmol; Frederic A Meunier; Jürgen Götz
Journal:  Nat Rev Neurol       Date:  2017-12-15       Impact factor: 42.937

Review 9.  Ageing as a risk factor for neurodegenerative disease.

Authors:  Yujun Hou; Xiuli Dan; Mansi Babbar; Yong Wei; Steen G Hasselbalch; Deborah L Croteau; Vilhelm A Bohr
Journal:  Nat Rev Neurol       Date:  2019-09-09       Impact factor: 42.937

Review 10.  The neuropathological diagnosis of Alzheimer's disease.

Authors:  Michael A DeTure; Dennis W Dickson
Journal:  Mol Neurodegener       Date:  2019-08-02       Impact factor: 14.195

View more
  9 in total

1.  Carnosic Acid Attenuates AβOs-Induced Apoptosis and Synaptic Impairment via Regulating NMDAR2B and Its Downstream Cascades in SH-SY5Y Cells.

Authors:  Wen-Ying Liu; Yan Li; Yan Li; Ling-Zhi Xu; Jian-Ping Jia
Journal:  Mol Neurobiol       Date:  2022-10-13       Impact factor: 5.682

2.  Fyn nanoclustering requires switching to an open conformation and is enhanced by FTLD-Tau biomolecular condensates.

Authors:  Ramón Martínez-Mármol; Christopher Small; Anmin Jiang; Tishila Palliyaguru; Tristan P Wallis; Rachel S Gormal; Jean-Baptiste Sibarita; Jürgen Götz; Frédéric A Meunier
Journal:  Mol Psychiatry       Date:  2022-10-18       Impact factor: 13.437

Review 3.  Emerging insights into synapse dysregulation in Alzheimer's disease.

Authors:  Raquel Martínez-Serra; Lidia Alonso-Nanclares; Kwangwook Cho; K Peter Giese
Journal:  Brain Commun       Date:  2022-04-08

4.  Claudin-5 binder enhances focused ultrasound-mediated opening in an in vitro blood-brain barrier model.

Authors:  Liyu Chen; Ratneswary Sutharsan; Jonathan Lf Lee; Esteban Cruz; Blaise Asnicar; Tishila Palliyaguru; Joanna M Wasielewska; Arnaud Gaudin; Jae Song; Gerhard Leinenga; Jürgen Götz
Journal:  Theranostics       Date:  2022-01-31       Impact factor: 11.556

5.  APOE ε4 in Depression-Associated Memory Impairment-Evidence from Genetic and MicroRNA Analyses.

Authors:  Sarah Bonk; Kevin Kirchner; Sabine Ameling; Linda Garvert; Henry Völzke; Matthias Nauck; Uwe Völker; Hans J Grabe; Sandra Van der Auwera
Journal:  Biomedicines       Date:  2022-06-30

6.  Nanoscale regulation of Ca2+ dependent phase transitions and real-time dynamics of SAP97/hDLG.

Authors:  Premchand Rajeev; Nivedita Singh; Adel Kechkar; Corey Butler; Narendrakumar Ramanan; Jean-Baptiste Sibarita; Mini Jose; Deepak Nair
Journal:  Nat Commun       Date:  2022-07-22       Impact factor: 17.694

7.  The lateral entorhinal cortex is a hub for local and global dysfunction in early Alzheimer's disease states.

Authors:  Francesca Mandino; Ling Yun Yeow; Renzhe Bi; Lee Sejin; Han Gyu Bae; Seung Hyun Baek; Chun-Yao Lee; Hasan Mohammad; Corey Horien; Chai Lean Teoh; Jasinda H Lee; Mitchell Kp Lai; Sangyong Jung; Yu Fu; Malini Olivo; John Gigg; Joanes Grandjean
Journal:  J Cereb Blood Flow Metab       Date:  2022-04-25       Impact factor: 6.960

Review 8.  Flying under the radar: CDH2 (N-cadherin), an important hub molecule in neurodevelopmental and neurodegenerative diseases.

Authors:  Zsófia I László; Zsolt Lele
Journal:  Front Neurosci       Date:  2022-09-23       Impact factor: 5.152

9.  Single-molecule imaging reveals Tau trapping at nanometer-sized dynamic hot spots near the plasma membrane that persists after microtubule perturbation and cholesterol depletion.

Authors:  Pranesh Padmanabhan; Andrew Kneynsberg; Esteban Cruz; Rumelo Amor; Jean-Baptiste Sibarita; Jürgen Götz
Journal:  EMBO J       Date:  2022-08-25       Impact factor: 14.012

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.